Innovation Fund

Innovation Fund is sponsored by American Diabetes Association. The ADA's Innovation Fund invests in innovative companies developing therapeutics, diagnostics, medical devices, and digital health solutions across the diabetes and cardiometabolic landscape, with a focus on solutions that advance the standard of care for people living with diabetes and related conditions, including Type 1 Diabetes.

The American Diabetes Association Announces Winners of the Innovation Challenge to Transform Diabetes Care This challenge Kickstarts additional investments through the new ADA Innovation Fund CHICAGO , June 21, 2025 /PRNewswire/ -- As the American Diabetes Association ® (ADA) celebrates its 85 th anniversary, it continues to fuel transformative progress in the fight to end diabetes—and increasingly, obesity.

This year's Innovation Challenge , held during the ADA's 85 th Scientific Sessions, highlighted bold ideas driving the future of diabetes treatment and support. Five visionary finalists presented their innovations on the main stage before a panel of expert judges and a live audience.

Three outstanding winners were selected for their potential to revolutionize diabetes care: Kihealth, MYNERVA, and Kayothera, INC. "One of the biggest things we've learned in our 85 years is that in the fight to end diabetes, every new bit of knowledge, every advancement in treatment, every novel idea matters.

We're proud to support these innovators as they help shape a future free of diabetes and all its burdens," said Elle Uh , the ADA's chief strategy officer and chief of staff. This year's winners and finalists included: Winner: Kihealth—A diagnostic test to measure the rate of beta cell death through a liquid biopsy, providing patients and clinicians with a clear view of metabolic health and an earlier window into disease development.

Winner: MYNERVA—An AI-driven neuroprosthetic smart sock for diabetes-related neuropathy to reduce pain and regain stability. Winner: Kayothera, INC—A first-in-class antagonist of the undruggable retinoid pathway to treat and potentially reverse type 2 diabetes. Finalist: BioDynamik, Inc.—An orthopedic-driven angiogenesis to restore perfusion for the healing of recalcitrant ischemic ulcers.

Finalist: Generated Health—A chatbot combining AI-driven automation and human-like empathy with a simple text-based platform designed to support both patients and health care teams. The Innovation Challenge occurs at a critical time. Over 38 million Americans live with diabetes and about 125 million live with obesity.

To meet these interconnected epidemics head-on, the ADA is launching the ADA Innovation Fund, a venture philanthropy fund designed to advance the ADA's mission by investing in innovative, high-impact companies developing diabetes, obesity, and other comorbidity-related solutions.

Leveraging the ADA's 85-year history of funding hundreds of millions of dollars in innovative research grants, these investments aim to continue to accelerate mission-critical scientific breakthroughs, reduce health disparities, and promote sustainable health care solutions. The American Diabetes Association (ADA) is the nation's leading voluntary health organization fighting to end diabetes and helping people thrive.

This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure—and we're not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we're fighting for them all.

To learn more or to get involved, visit us at diabetes. org or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook ( American Diabetes Association ), Spanish Facebook ( Asociación Americana de la Diabetes ), LinkedIn ( American Diabetes Association ), and Instagram ( @AmDiabetesAssn ).

To learn more about how we are advocating for everyone affected by diabetes, visit us on X ( @AmDiabetesAssn ).

SOURCE American Diabetes Association more press release views with New Standards of Care in Overweight and Obesity Section: Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults Today, the Obesity Association, a division of the American Diabetes Association® (the association), announced the next section in the Standards of...

New Survey: Nearly 40 Percent of Insulin Users Polled Pay More Than $150 Per Month New polling released today by the American Diabetes Association® (ADA) finds that among respondents who rely on insulin, 72% report paying more than... More Releases From This Source News Releases in Similar Topics